早期浸润性乳腺癌或导管原位癌的部分乳腺照射:ASTRO临床实践指南
本指南由ASTRO工作组制定,基于美国医疗保健研究与质量局提供的系统评价,针对早期浸润性乳腺癌或导管原位癌患者,就部分乳腺照射(PBI)的适应证和技术给出循证推荐。PBI采用三维适形放疗、调强放疗、多导管近距离治疗和单入口近距离治疗时,长期随访下同侧乳腺复发率与全乳照射(WBI)相似。
要点
- 三维适形放疗、调强放疗、多导管近距离治疗和单入口近距离治疗的PBI,长期随访下同侧乳腺复发率与WBI相似。
- 单独术中放疗与WBI相比同侧乳腺复发率更高。
- 基于晚期毒性顾虑,每日或隔日外照射PBI方案优于每日两次方案。
核心结论
- 基于已发表数据,ASTRO工作组提出推荐以指导PBI的最佳临床实践。
研究设计与样本
- ASTRO召集工作组,基于美国医疗保健研究与质量局提供的系统评价,采用预定义的共识构建方法和证据质量与推荐强度分级系统制定推荐。
主要发现
- 采用三维适形放疗、调强放疗、多导管近距离治疗和单入口近距离治疗实施的PBI,长期随访下同侧乳腺复发率与WBI相似。
- 部分患者特征和肿瘤特征在随机对照试验中代表性不足,难以完全定义这些特征患者的同侧乳腺复发风险。
- 单独术中放疗与WBI相比同侧乳腺复发率更高。
关键数值与推荐
- 指南概述了PBI适用的剂量分割方案、靶区勾画和治疗计划参数。
- 基于晚期毒性顾虑,每日或隔日外照射PBI方案优于每日两次方案。
临床怎么用
- 原文未据此给出推荐。
局限性
- 部分患者特征和肿瘤特征在随机对照试验中代表性不足,难以完全定义这些特征患者的同侧乳腺复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This guideline provides evidence-based recommendations on appropriate indications and techniques for partial breast irradiation (PBI) for patients with early-stage invasive breast cancer and ductal carcinoma in situ. METHODS: ASTRO convened a task force to address 4 key questions focused on the appropriate indications and techniques for PBI as an alternative to whole breast irradiation (WBI) to result in similar rates of ipsilateral breast recurrence (IBR) and toxicity outcomes. Also addressed were aspects related to the technical delivery of PBI, including dose-fractionation regimens, target volumes, and treatment parameters for different PBI techniques. The guideline is based on a systematic review provided by the Agency for Healthcare Research and Quality. Recommendations were created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. RESULTS: PBI delivered using 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, multicatheter brachytherapy, and single-entry brachytherapy results in similar IBR as WBI with long-term follow-up. Some patient characteristics and tumor features were underrepresented in the randomized controlled trials, making it difficult to fully define IBR risks for patients with these features. Appropriate dose-fractionation regimens, target volume delineation, and treatment planning parameters for delivery of PBI are outlined. Intraoperative radiation therapy alone is associated with a higher IBR rate compared with WBI. A daily or every-other-day external beam PBI regimen is preferred over twice-daily regimens due to late toxicity concerns. CONCLUSIONS: Based on published data, the ASTRO task force has proposed recommendations to inform best clinical practices on the use of PBI.
引用
- Shaitelman SF, Anderson BM, Arthur DW, et al. Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol. 2023. PMID: 37977261. doi:10.1016/j.prro.2023.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。